Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01356927 · ClinicalTrials.gov registry record
Same-day Long-acting Reversible Contraception for Medication Abortion
A clinical trial of Abortion, Induced, sponsored by Boston University.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT01356927: Completed study of Abortion, Induced, sponsored by Boston University.
NCT01356927 is a study of Abortion, Induced that has completed, run by Boston University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01356927, a study of Abortion, Induced, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Contraception after abortion is an important public health issue, as women who have an abortion are at high risk for additional unintended pregnancy. In the context of first trimester medical abortion, the standard of care is to administer long-acting reversible contraception, including the etonogestrel implant (Implanon) and depot medroxyprogesterone acetate (DMPA), at a follow-up appointment after the abortion. The investigators plan to conduct a prospective observational pilot study to evaluate the satisfaction of subjects who have selected either the contraceptive implant or DMPA given on the first day of medical abortion, as opposed to at a follow-up appointment. The investigators will also assess the continuation of DMPA and Implanon at 3, 6, 9, and 12 months after the initial date of administration. In addition, the investigators will assess the total days of bleeding after the abortion, follow-up rate for evaluation of completion of medical abortion, and efficacy of medical abortion. A total of 40 participants will be recruited, 20 who choose Implanon and 20 who choose DMPA. They will be asked to fill out questionnaires during the course of the study, and will be followed for one year. The study duration including data analysis will be two years.
Conditions Studied
Interventions
- DRUG DMPA
- DRUG Etonogestrel implant
Study Locations (1)
Massachusetts
- Boston University Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-04 |
What the finished NCT01356927 record still lists
NCT01356927 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Abortion, Induced appearing as the primary indexed condition, and to 2 interventions - of which DMPA is the first listed.
NCT01356927 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01356927 about?
NCT01356927 is a clinical study titled "Same-day Long-acting Reversible Contraception for Medication Abortion". Contraception after abortion is an important public health issue, as women who have an abortion are at high risk for additional unintended pregnancy. In the context of first trimester medical abortion, the standard of care is to administer long-acting reversible contraception, including the etonoges...
What is the current status of trial NCT01356927?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-05. Estimated completion is 2014-04.
What conditions does trial NCT01356927 study?
This clinical trial studies the following conditions: Abortion, Induced.
What interventions are being tested in trial NCT01356927?
The interventions under investigation include: DMPA (DRUG), Etonogestrel implant (DRUG).
Who is sponsoring clinical trial NCT01356927?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01356927 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abortion, Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia